|
All loci:
Mm; a, nonagouti
Hs; ABT1, activator of basal transcription 1
Rn; Akt1, v-akt murine thymoma viral oncogene homolog 1
Mm; Akt1, thymoma viral proto-oncogene 1
Hs; AKT1, v-akt murine thymoma viral oncogene homolog 1
Hs; AKT2, v-akt murine thymoma viral oncogene homolog 2
Hs; AKT3, v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
Mm; Apbb1, amyloid beta (A4) precursor protein-binding, family B, member 1
Hs; APBB1, amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
Mm; Apc, adenomatosis polyposis coli
Hs; APC, adenomatosis polyposis coli
Mm; Apoe, apolipoprotein E
Hs; APOE, apolipoprotein E
Mm; App, amyloid beta (A4) precursor protein
Hs; APP, amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease)
Hs; ASIP, agouti signaling protein, nonagouti homolog (mouse)
Mm; Atm, ataxia telangiectasia mutated homolog (human)
Hs; ATM, ataxia telangiectasia mutated (includes complementation groups A, C and D)
Hs; ATP6, mitochondrially encoded ATP synthase 6
Hs; ATP8, mitochondrially encoded ATP synthase 8
Mm; Bax, Bcl2-associated X protein
Hs; BAX, BCL2-associated X protein
Hs; BLM, Bloom syndrome
Mm; Blm, Bloom syndrome homolog (human)
Mm; Ccl2, chemokine (C-C motif) ligand 2
Hs; CCL2, chemokine (C-C motif) ligand 2
Mm; Cd14, CD14 antigen
Hs; CD14, CD14 antigen
Mm; Cdkn2a, cyclin-dependent kinase inhibitor 2A
Hs; CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
Mm; Cdkn2b, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
Hs; CDKN2B, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
Mm; Ckn1, Cockayne syndrome 1 homolog (human)
Mm; Co1, cytochrome c oxidase I, mitochondrial
Hs; CO1, mitochondrially encoded cytochrome c oxidase I
Mm; Co2, cytochrome c oxidase II, mitochondrial
Hs; CO2, mitochondrially encoded cytochrome c oxidase II
Mm; Co3, cytochrome c oxidase III, mitochondrial
Hs; CO3, mitochondrially encoded cytochrome c oxidase III
Hs; CPB2, carboxypeptidase B2 (plasma, carboxypeptidase U)
Mm; Crp, C-reactive protein, petaxin related
Hs; CRP, C-reactive protein, pentraxin-related
Mm; Cytb, cytochrome b, mitochondrial
Mm; Dguok, deoxyguanosine kinase
Hs; DGUOK, deoxyguanosine kinase
Mm; Ecgf1, endothelial cell growth factor 1 (platelet-derived)
Hs; ECGF1, endothelial cell growth factor 1 (platelet-derived)
Mm; Endog, endonuclease G
Hs; ENDOG, endonuclease G
Mm; Ercc2, excision repair cross-complementing rodent repair deficiency, complementation group 2
Hs; ERCC2, excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)
Hs; ERCC8, excision repair cross-complementing rodent repair deficiency, complementation group 8
Mm; F2, coagulation factor II
Hs; F2, coagulation factor II (thrombin)
Mm; F7, coagulation factor VII
Hs; F7, coagulation factor VII (serum prothrombin conversion accelerator)
Mm; F9, coagulation factor IX
Hs; F9, coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B)
Mm; Fga, fibrinogen, alpha polypeptide
Hs; FGA, fibrinogen, A alpha polypeptide
Mm; Fgb, fibrinogen, B beta polypeptide
Hs; FGB, fibrinogen, B beta polypeptide
Mm; Fgg, fibrinogen, gamma polypeptide
Hs; FGG, fibrinogen, gamma polypeptide
Mm; Flt1, FMS-like tyrosine kinase 1
Hs; FLT1, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
Mm; Foxc2, forkhead box C2
Hs; FOXC2, forkhead box C2 (MFH-1, mesenchyme forkhead 1)
Mm; Foxd1, forkhead box D1
Hs; FOXD1, forkhead box D1
Hs; FOXO1A, forkhead box O1A (rhabdomyosarcoma)
Hs; FOXO3A, forkhead box O3A
Hs; FOXO6, forkhead box protein O6
Hs; FOXP1, forkhead box P1
Hs; FOXP2, forkhead box P2
Hs; FOXP4, forkhead box P4
Mm; Gadd45a, growth arrest and DNA-damage-inducible 45 alpha
Hs; GADD45A, growth arrest and DNA-damage-inducible, alpha
Mm; Gadd45b, growth arrest and DNA-damage-inducible 45 beta
Hs; GADD45B, growth arrest and DNA-damage-inducible, beta
Mm; Gadd45g, growth arrest and DNA-damage-inducible 45 gamma
Hs; GADD45G, growth arrest and DNA-damage-inducible, gamma
Hs; GAPD, glyceraldehyde-3-phosphate dehydrogenase
Mm; Ghr, growth hormone receptor
Hs; GHR, growth hormone receptor
Mm; Ghrhr, growth hormone releasing hormone receptor
Hs; GHRHR, growth hormone releasing hormone receptor
Mm; Hspa9a, heat shock protein, A
Hs; HSPA9B, heat shock 70kDa protein 9B (mortalin-2)
Mm; Hspca, heat shock protein 1, alpha
Hs; HSPCA, heat shock 90kDa protein 1, alpha
Hs; IGF1, insulin-like growth factor 1 (somatomedin C)
Hs; IGF1R, insulin-like growth factor 1 receptor
Mm; Igf1r, insulin-like growth factor I receptor
Hs; IGF2, insulin-like growth factor 2 (somatomedin A)
Hs; IGF2R, insulin-like growth factor 2 receptor
Hs; IKBKB, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
Mm; Il1b, interleukin 1 beta
Hs; IL1B, interleukin 1, beta
Hs; IL1R1, interleukin 1 receptor, type I
Mm; Il2, interleukin 2
Hs; IL2, interleukin 2
Mm; Il2ra, interleukin 2 receptor, alpha chain
Hs; IL2RA, interleukin 2 receptor, alpha
Mm; Il2rg, interleukin 2 receptor, gamma chain
Hs; IL2RG, interleukin 2 receptor, gamma (severe combined immunodeficiency)
Mm; Il6, interleukin 6
Hs; IL6, interleukin 6 (interferon, beta 2)
Hs; IL6ST, interleukin 6 signal transducer (gp130, oncostatin M receptor)
Hs; INS, insulin
Hs; INSR, insulin receptor
Mm; Insr, insulin receptor
Hs; INSRL, insulin receptor-like
Hs; INSRR, insulin receptor-related receptor
Hs; IRAK4, interleukin-1 receptor-associated kinase 4
Hs; IRS1, insulin receptor substrate 1
Hs; IRS2, insulin receptor substrate 2
Hs; IRS3L, insulin receptor substrate 3-like
Hs; IRS4, insulin receptor substrate 4
Mm; Ivns1abp, influenza virus NS1A binding protein
Mm; Kl, klotho
Hs; KL, klotho
Mm; LOC14433, similar to glyceraldehyde-3-phosphate dehydrogenase
Hs; MAP3K7, mitogen-activated protein kinase kinase kinase 7
Mm; Mapk1, mitogen activated protein kinase 1
Hs; MAPK1, mitogen-activated protein kinase 1
Hs; MAPK14, mitogen-activated protein kinase 14
Mm; Mapk3, mitogen activated protein kinase 3
Hs; MAPK3, mitogen-activated protein kinase 3
Hs; MIF, macrophage migration inhibitory factor (glycosylation-inhibiting factor)
Hs; MLLT7, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7
Hs; MORF4, mortality factor 4
Mm; Msra, methionine sulfoxide reductase A
Hs; MSRA, methionine sulfoxide reductase A
Hs; MYD88, myeloid differentiation primary response gene (88)
Hs; ND1, mitochondrially encoded NADH dehydrogenase 1
Hs; ND2, mitochondrially encoded NADH dehydrogenase 2
Hs; ND3, mitochondrially encoded NADH dehydrogenase 3
Hs; ND4, mitochondrially encoded NADH dehydrogenase 4
Hs; ND4L, mitochondrially encoded NADH dehydrogenase 4L
Hs; ND5, mitochondrially encoded NADH dehydrogenase 5
Hs; ND6, mitochondrially encoded NADH dehydrogenase 6
Mm; Nfkb1, nuclear factor of kappa light chain gene enhancer in B-cells 1, p105
Hs; NFKB1, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)
Mm; Nfkbia, nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha
Hs; NFKBIA, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
Hs; NR1H2, nuclear receptor subfamily 1, group H, member 2
Hs; NR1H3, nuclear receptor subfamily 1, group H, member 3
Hs; NR1H4, nuclear receptor subfamily 1, group H, member 4
Mm; Ogg1, 8-oxoguanine DNA-glycosylase 1
Hs; OGG1, 8-oxoguanine DNA glycosylase
Mm; Park2, parkin
Hs; PARK2, Parkinson disease (autosomal recessive, juvenile) 2, parkin
Mm; Pbk, PDZ binding kinase
Hs; PBK, PDZ binding kinase
Hs; PDPK1, 3-phosphoinositide dependent protein kinase-1
Mm; Peo1, progressive external ophthalmoplegia 1 (human)
Hs; PEO1, progressive external ophthalmoplegia 1
Hs; PIK3C2A, phosphoinositide-3-kinase, class 2, alpha polypeptide
Hs; PIK3C2B, phosphoinositide-3-kinase, class 2, beta polypeptide
Hs; PIK3C2G, phosphoinositide-3-kinase, class 2, gamma polypeptide
Hs; PIK3CA, phosphoinositide-3-kinase, catalytic, alpha polypeptide
Hs; PIK3CB, phosphoinositide-3-kinase, catalytic, beta polypeptide
Hs; PIK3CD, phosphoinositide-3-kinase, catalytic, delta polypeptide
Hs; PIK3CG, phosphoinositide-3-kinase, catalytic, gamma polypeptide
Hs; PIK3R1, phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha)
Hs; PIK3R1OS, phosphoinositide-3-kinase, regulatory subunit 1, opposite strand
Hs; PIK3R2, phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta)
Hs; PIK3R3, phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma)
Hs; PIK3R4, phosphoinositide-3-kinase, regulatory subunit 4, p150
Hs; PIK3R5, phosphoinositide-3-kinase, regulatory subunit 5, p101
Mm; Pit1, pituitary specific transcription factor 1
Mm; Plat, plasminogen activator, tissue
Hs; PLAT, plasminogen activator, tissue
Mm; Plau, plasminogen activator, urokinase
Hs; PLAU, plasminogen activator, urokinase
Mm; Plaur, urokinase plasminogen activator receptor
Hs; PLAUR, plasminogen activator, urokinase receptor
Mm; Plg, plasminogen
Hs; PLG, plasminogen
Hs; PLK1, polo-like kinase 1 (Drosophila)
Hs; PLK2, polo-like kinase 2 (Drosophila)
Hs; PLK3, polo-like kinase 3 (Drosophila)
Mm; Polg, polymerase (DNA directed), gamma
Hs; POLG, polymerase (DNA directed), gamma
Mm; Polg2, polymerase (DNA directed), gamma 2, accessory subunit
Hs; POLG2, polymerase (DNA directed), gamma 2, accessory subunit
Hs; POU1F1, POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1)
Hs; PPARA, peroxisome proliferative activated receptor, alpha
Hs; PPARBP, PPAR binding protein
Hs; PPARD, peroxisome proliferative activated receptor, delta
Hs; PPARG, peroxisome proliferative activated receptor, gamma
Hs; PPARGC1A, peroxisome proliferative activated receptor, gamma, coactivator 1, alpha
Hs; PPARGC1B, peroxisome proliferative activated receptor, gamma, coactivator 1, beta
Hs; PPRC1, peroxisome proliferative activated receptor, gamma, coactivator-related 1
Hs; PRAP1, proline-rich acidic protein 1
Mm; Prap1, proline-rich acidic protein 1
Mm; Proc, protein C
Hs; PROC, protein C (inactivator of coagulation factors Va and VIIIa)
Mm; Prop1, paired like homeodomain factor 1
Hs; PROP1, prophet of Pit1, paired-like homeodomain transcription factor
Mm; Psen1, presenilin 1
Hs; PSEN1, presenilin 1 (Alzheimer disease 3)
Mm; Psen2, presenilin 2
Hs; PSEN2, presenilin 2 (Alzheimer disease 4)
Hs; PTEN, phosphatase and tensin homolog (mutated in multiple advanced cancers 1)
Hs; RARA, retinoic acid receptor, alpha
Hs; RARB, retinoic acid receptor, beta
Hs; RARG, retinoic acid receptor, gamma
Hs; RELA, v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian)
Mm; Retn, resistin
Hs; RETN, resistin
Mm; Rgn, regucalcin
Hs; RGN, regucalcin (senescence marker protein-30)
Hs; RIPK1, receptor (TNFRSF)-interacting serine-threonine kinase 1
Hs; RIPK2, receptor-interacting serine-threonine kinase 2
Hs; RIPK3, receptor-interacting serine-threonine kinase 3
Hs; RIPK4, receptor-interacting serine-threonine kinase 4
Hs; RIPK5, receptor interacting protein kinase 5
Hs; RXRA, retinoid X receptor, alpha
Hs; RXRB, retinoid X receptor, beta
Hs; RXRG, retinoid X receptor, gamma
Mm; Serpina1, serine (or cysteine) proteinase inhibitor, clade A, member 1
Hs; SERPINA1, serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
Mm; Serpine1, serine (or cysteine) proteinase inhibitor, clade E, member 1
Hs; SERPINE1, serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
Mm; Shc1, src homology 2 domain-containing transforming protein C1
Hs; SHC1, SHC (Src homology 2 domain containing) transforming protein 1
Hs; SHC2, SHC (Src homology 2 domain containing) transforming protein 2
Hs; SHC3, src homology 2 domain containing transforming protein C3
Hs; SHCBP1, SHC SH2-domain binding protein 1
Hs; SIRT1, sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae)
Mm; Slc25a4, solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
Hs; SLC25A4, solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
Mm; Slc2a4, solute carrier family 2 (facilitated glucose transporter), member 4
Hs; SLC2A4, solute carrier family 2 (facilitated glucose transporter), member 4
Hs; SLC2A4RG, SLC2A4 regulator
Mm; Snca, synuclein, alpha
Hs; SNCA, synuclein, alpha (non A4 component of amyloid precursor)
Mm; Sod1, superoxide dismutase 1, soluble
Hs; SOD1, superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
Mm; Sod2, superoxide dismutase 2, mitochondrial
Hs; SOD2, superoxide dismutase 2, mitochondrial
Mm; Ssbp, signal sequence binding protein
Hs; SSBP1, single-stranded DNA binding protein 1
Hs; STAT3, signal transducer and activator of transcription 3 (acute-phase response factor)
Hs; TAF6, TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa
Mm; Terc, telomerase RNA component
Hs; TERC, telomerase RNA component
Mm; Tert, telomerase reverse transcriptase
Hs; TERT, telomerase reverse transcriptase
Mm; Tfam, transcription factor A, mitochondrial
Hs; TFAM, transcription factor A, mitochondrial
Mm; Thbd, thrombomodulin
Hs; THBD, thrombomodulin
Hs; TK1, thymidine kinase 1, soluble
Mm; Tk2, thymidine kinase 2, mitochondrial
Hs; TK2, thymidine kinase 2, mitochondrial
Mm; Tlr1, toll-like receptor 1
Hs; TLR1, toll-like receptor 1
Mm; Tlr2, toll-like receptor 2
Hs; TLR2, toll-like receptor 2
Hs; TLR3, toll-like receptor 3
Mm; Tlr4, toll-like receptor 4
Hs; TLR4, toll-like receptor 4
Hs; TLR5, toll-like receptor 5
Hs; TLR6, toll-like receptor 6
Mm; Tnf, tumor necrosis factor
Hs; TNF, tumor necrosis factor (TNF superfamily, member 2)
Hs; TNFAIP1, tumor necrosis factor, alpha-induced protein 1 (endothelial)
Hs; TNFAIP2, tumor necrosis factor, alpha-induced protein 2
Hs; TNFAIP3, tumor necrosis factor, alpha-induced protein 3
Hs; TNFAIP8, tumor necrosis factor, alpha-induced protein 8
Hs; TNFRSF1A, tumor necrosis factor receptor superfamily, member 1A
Hs; TOP1, topoisomerase (DNA) I
Hs; TOP1MT, topoisomerase (DNA) I, mitochondrial
Hs; TOP2A, topoisomerase (DNA) II alpha 170kDa
Hs; TOP3A, topoisomerase (DNA) III alpha
Mm; Top3b, topoisomerase (DNA) III beta
Hs; TOP3B, topoisomerase (DNA) III beta
Hs; TP53, tumor protein p53 (Li-Fraumeni syndrome)
Hs; TRADD, TNFRSF1A-associated via death domain
Hs; TRAF1, TNF receptor-associated factor 1
Hs; TRAF2, TNF receptor-associated factor 2
Mm; Trp53, transformation related protein 53
Mm; Uchl1, ubiquitin carboxy-terminal hydrolase L1
Hs; UCHL1, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
Mm; Ung, uracil-DNA glycosylase
Hs; UNG, uracil-DNA glycosylase
Hs; VEGF, vascular endothelial growth factor
Mm; Vegfa, vascular endothelial growth factor A
Mm; Vegfb, vascular endothelial growth factor B
Hs; VEGFB, vascular endothelial growth factor B
Mm; Vegfc, vascular endothelial growth factor C
Hs; VEGFC, vascular endothelial growth factor C
Mm; Wrn, Werner syndrome homolog (human)
Hs; WRN, Werner syndrome
|
|